Amy has gained experience working on contentious and non-contentious intellectual property matters, with a focus on patent litigation in the life sciences sector based on her background in Biochemistry.
Her non-contentious work has included advising on clinical trial agreements in a number of jurisdictions.
- Recent Work
- assisting Eli Lilly in its successful action against Janssen Alzheimer Immunotherapy for revocation of a patent concerning monoclonal antibodies for use in the treatment of Alzheimer’s disease.
- assisting Bayer HealthCare in proceedings concerning Bayer's patent relating to anti-TNF alpha monoclonal antibodies.
- assisting Aventis Pharma in the defence of an action for declarations of non-infringement and revocation of patents protecting an anti-cancer drug.
- assisting LEO Pharma in proceedings relating to LEO's patent for a new crystal form of vitamin D analogue.
Amy has an MSci degree in Biochemistry (First Class Honours) from Imperial College London. She joined Simmons & Simmons as a trainee solicitor in September 2009 and qualified into the Intellectual Property Department in September 2011.
During her training contract she spent time on secondment to the asset management arm of an international investment bank and to the firm’s Dubai office. Since qualifying she has also spent time on secondment to a major pharmaceutical company in London.